Virtus ETF Advisers’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,278	Closed	-$69.8K	–	749
2024 Q4	$69.8K	Buy	5,278 +827	+19%	+$14.2K	0.03%	379
2024 Q3	$85.7K	Buy	4,451 +78	+2%	+$1.61K	0.04%	403
2024 Q2	$89.8K	Buy	4,373 +14	+0.3%	+$293	0.04%	359
2024 Q1	$104K	Sell	4,359 -298	-6%	-$6.65K	0.06%	357
2023 Q4	$101K	Buy	4,657 +125	+3%	+$1.92K	0.06%	355
2023 Q3	$65.8K	Sell	4,532 -451	-9%	-$8.53K	0.04%	395
2023 Q2	$104K	Buy	4,983 +863	+21%	+$18K	0.06%	361
2023 Q1	$87K	Sell	4,120 -1,581	-28%	-$39.3K	0.05%	369
2022 Q4	$145K	Sell	5,701 -927	-14%	-$21.6K	0.08%	355
2022 Q3	$159K	Buy	6,628 +44	+0.7%	+$987	0.06%	345
2022 Q2	$127K	Sell	6,584 -2,139	-25%	-$35.6K	0.05%	366
2022 Q1	$152K	Sell	8,723 -515	-6%	-$8.67K	0.07%	226
2021 Q4	$202K	Sell	9,238 -2,003	-18%	-$37K	0.08%	205
2021 Q3	$215K	Sell	11,241 -594	-5%	-$9.9K	0.09%	251
2021 Q2	$203K	Buy	11,835 +7	+0.1%	+$128	0.08%	336
2021 Q1	$264K	Buy	11,828 +204	+2%	+$4.61K	0.11%	273
2020 Q4	$259K	Sell	11,624 -8,270	-42%	-$172K	0.11%	300
2020 Q3	$294K	Sell	19,894 -2,702	-12%	-$41.2K	0.15%	230
2020 Q2	$335K	Buy	+22,596	New	+$344K	0.16%	278